Private Equity

French pharma giant Servier acquires Day One Biopharmaceuticals, gaining a breakthrough pediatric cancer drug and signaling a major push into rare oncology.

Altius completes its acquisition of Lithium Royalty Corp., gaining a major foothold in the battery metals market and a new influential shareholder.

With new CEO Anthony Rotoli and Accel-KKR's backing, MCM Technology aims to conquer the public safety software market through major platform innovation.

With $115M in new funding and key government support, Northisle is set to accelerate its promising North Island Project, a critical asset for Canada.

A powerful real estate PAC celebrates wins in the Texas primaries, but can its allies tackle the state's soaring property taxes and housing crunch?

Newcomer Kavayn aims to disrupt the booming kava industry by combining direct farmer financing in the Pacific with high-potency CO2 extraction methods.

In a major industry shake-up, KJA brings Soberman Engineering into the fold, welcoming back a top expert to dominate Canada's new construction market.

A recent scientific review links low glutathione to brain disease. A new supplement claims to solve the delivery problem. Is this the future of cognitive health?

Lush Life Hospitality Group opens Bull Moose, an ultra-discreet 12-seat members' lounge hidden in Oyster Bay, signaling a new trend in suburban luxury.

With its key earnings call on March 12, Aemetis's recent tax credit sales and project milestones are weighed against past financial performance.

Western Alliance Bank accuses Jefferies of fraud over a loan tied to the bankrupt First Brands Group, exposing a multi-billion dollar scheme.

The parent of GOL and Avianca is adding seven A330-900s, signaling a major strategic push to challenge rivals in the lucrative long-haul market.

Alpha Modus resolves its patent lawsuit against Brookshire Grocery, highlighting an aggressive IP strategy in the booming AI retail technology sector.

Allarity Therapeutics lands a crucial $20M debt deal to push its unique ovarian cancer drug, stenoparib, through late-stage trials and extend its runway to 2028.

AIRO Group will present its future vision at a major tech conference, facing investor scrutiny amid ambitious growth plans and recent financial hurdles.

With key lithium projects advancing from Mali to Argentina, LRC's portfolio updates signal a ramp-up in global supply for the electric vehicle revolution.

Electronics giant TCL is blanketing Milan with ads and experiences, making a bold strategic play to own the Olympic spotlight ahead of the 2026 Winter Games.

Over 110 exchanges unite for women's rights, but the real push is for measurable change in corporate transparency, leadership, and investment strategy.

An oversubscribed offering provides a critical cash infusion for RER's Wyoming projects, but market skepticism and permitting hurdles test its long journey.

Ero Copper reports record 2025 production and soaring profits, yet a planned slow start to 2026 has investors weighing near-term hurdles against long-term growth.